Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sean P FitzwaterDavid A J Moore

Abstract

Effective tuberculosis control is compromised by a lack of clarity about the timeframe of viable Mycobacterium tuberculosis shedding after treatment initiation under programmatic conditions. This study quantifies time to conversion from smear and culture positivity to negativity in unselected tuberculosis patients receiving standardized therapy in a directly observed therapy short-course (DOTS) program. Longitudinal cohort study following up 93 adults initiating tuberculosis therapy in Lima, Peru. Baseline culture and drug susceptibility tests (DSTs) were performed using the MBBacT, proportion, and microscopic observation drug susceptibility (MODS) methods. Smear microscopy and MODS liquid culture were performed at baseline and weekly for 4 weeks then every other week for 26 weeks. Median conversion time from culture positivity to culture negativity of 38.5 days was unaffected by baseline smear status. Patients with fully susceptible tuberculosis had a median time to culture conversion of 37 days; 10% remained culture positive at day 60. Delayed culture conversion was associated with multidrug resistance, regardless of DST method used; non-multidrug resistance as defined by the proportion method and MODS (but not MBBacT) was al...Continue Reading

Citations

Oct 11, 2013·Journal of the Royal Army Medical Corps·Matthew K O'Shea, D Wilson
Apr 9, 2011·Biomarkers in Medicine·Aron ChakeraMichaela Lucas
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashwin S Dharmadhikari, Edward Nardell
Feb 18, 2016·Transactions of the Royal Society of Tropical Medicine and Hygiene·Grace H Huynh
Feb 13, 2016·The Lancet Infectious Diseases·Tom A YatesIbrahim Abubakar
Jan 8, 2014·Tropical Medicine & International Health : TM & IH·Solomon A YimerGunnar A Bjune
Aug 13, 2014·La Revue de médecine interne·C Guillet-CarubaF Doucet-Populaire
Jan 17, 2014·The Lancet. Respiratory Medicine·Mark P Nicol
Apr 24, 2016·BMJ Open·Alvaro ProañoUNKNOWN Tuberculosis Working Group in Peru
Aug 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Payam NahidAndrew Vernon
Feb 7, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Eskild PetersenAlimuddin Zumla
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alvaro ProañoUNKNOWN Tuberculosis Working Group in Peru
Jan 26, 2017·Tuberculosis and Respiratory Diseases·Yousang KoYong Bum Park
Mar 8, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christine Sekaggya-WiltshireJan S Fehr
Apr 27, 2019·The European Respiratory Journal·Giovanni Battista MiglioriMasoud Dara
Nov 16, 2017·Infectious Diseases of Poverty·Senedu Bekele GebreegziabherSolomon Abebe Yimer
Jul 21, 2021·Antimicrobial Resistance and Infection Control·Ana PaleckyteTimothy D McHugh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Alma TostmannDick van Soolingen
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Richard LongPeter Tilley
Tropical Medicine & International Health : TM & IH
Collins K AhorluMitchell G Weiss
© 2021 Meta ULC. All rights reserved